Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis Meeting Abstract
| Authors: | McNeish, I. A.; Oza, A. M.; Coleman, R. L.; Scott, C. L.; Konecny, G. E.; Tinker, A.; O'Malley, D. M.; Brenton, J.; Kristeleit, R. S.; Bell-Mcguinn, K.; Oaknin, A.; Leary, A.; Lin, K.; Raponi, M.; Giordano, H.; Goble, S.; Rolfe, L.; Yelensky, R.; Allen, A. R.; Swisher, E. M. |
| Abstract Title: | Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901166 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.5508 |
| Notes: | Meeting Abstract: 5508 -- Source: Wos |
